Welcome!

News Feed Item

OBN's 2013 Annual Awards Dinner Celebrates UK Bioscience Success Stories

OXFORD, England, October 1, 2013 /PRNewswire/ --


 http://www.obn.org.uk/obn_/menu.php?p=rss&rn=rssfeed&prechk_news=1

OBN's Annual Awards Dinner this evening celebrated the achievements and major success stories in biotech, medtech and diagnostics over the past year at a black tie event at The Ashmolean Museum, Oxford. The Awards seek to highlight the many achievements of the UK's bioscience sector in raising funds, executing deals and supporting innovation. OBN's Awards recognize these achievements, taking into account its significance for the stage of development of a nominated life sciences company, as well as the scale of the achievement.

The 2013 award winners were:

Circassia, Best New Biotech Development Programme

Award Presented by J A Kemp

Circassia's ToleroMune® cat allergy treatment maintained symptom improvement two years after the start of Short-Course Therapy in a phase II clinical trial, while their HDM-SPIRE treatment for house dust mite allergy also achieved long-term symptom reduction.

OrganOx, Best New Medtech Development Programme

Award Presented by Citigate

OrganOx has developed metra™ - a system which enables the repair, preservation and objective viability assessment of livers prior to transplantation. It has already been used successfully for several transplantation procedures in 2013.

Autifony Therapeutics, Best Emerging Biotech

Award Presented by James Cowper

Autifony is developing new drugs to treat hearing disorders by targeting specific ion channels which regulate neuronal activity within the auditory system. A top up series A round of £5.5m in June 2013 brings funds raised to £15.5m, plus a £2.75m collaboration also announced in 2013.

Parsortix, Best Emerging Medtech

Award Presented by Team Consulting

Angle plc spin-out Parsortix has separation technology which captures very rare circulating tumour cells (CTCs) in cancer patient blood. They have launched a research market product but also aim to secure CE Mark approval for the clinical market in 2013, with FDA approval sought during 2014.

Karus Therapeutics, Best Biotech Fundraiser

Award Presented by Akesios Associates

Karus raised £5m as the first tranche of a Series B investment in September 2012 from top tier investors SV Life Sciences (UK and International), New Leaf Venture Partners (US), Novo A/S (Denmark), IP Group (UK), Esperante Ventures (Netherlands) and a number of Angel investors. This award recognizes the progression the company has made in securing this fundraising from this syndicate.

Glide Pharma, Best Medtech Fundraiser

Award Presented by Milton Park

Glide Pharma raised £14m in Feb 2013 from Invesco Perpetual and existing investors.  This will enable the scale-up of manufacturing for its Glide SDI injector system (both drug and device).  Glide won an additional £2.3m of project funding from TSB in the form of a Biomedical Catalyst competition award.

Immunocore,  Best Biotech Dealmaker

Award Presented by E&Y

Immunocore secured a £142m deal with GSK (July 2013) for ImmTACs to treat cancer and viral disease and a research collaboration and licensing agreement with Genentech (June 2013), valued at up to £300m. The deals come with potential fees and milestone payments which could be worth hundreds of millions according to industry commentators.

Oxford Gene Technology,  Best Medtech Dealmaker

Award Presented by Wilmerhale

Oxford Gene Technology collaboratively developed  a panel of 58 cancer-associated genes for diagnostic purposes with Birmingham and Salisbury NHS Regional Genetics Laboratories backed by £1.16m in funding from the TSB (May 2013).

Technology Strategy Board,  Highest Impact Investor

Award Presented by OBN

This award is made to the TSB in recognition of the impact of the Biomedical Catalyst, making investments of up to £122m over its first 18 months, including up to 112 awards to small-to-medium sized companies in the sector.

Shire,  Best Pharma BD&L Team

Award Presented by World Courier

Shire strengthened its rare disease and opthalmology portfolio with a number of significant acquisitions including Premacure AB, Lotus Tissue Repair, and SARCode Bioscience, and entered into a number of new co-development deals.

Dr Jon Rees, OBN's CEO, said: "This year's awards highlight the vibrancy and variety of the broader life sciences sector in the UK and, despite tough financing conditions, the progress companies have been able to make and the tangible successes delivered. As OBN expands its sphere of influence across the UK, we were delighted to welcome a larger number of entrepreneurs from across the UK to the Awards Dinner than any previous year."

**Photographs of the Awards are available on request**


About OBN


OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors within the Golden Triangle biocluster (formed by the cities of Oxford, Cambridge and London) and beyond, providing networking, partnering, group purchasing, advocacy and cluster consultancy.

Through our delivery of Europe's third largest annual biopartnering and investment conference 'BioTrinity', which is expected to attract 1000+ delegates from 30 countries, OBN will generate more R&D-company-to-investor interactions than anyone else in Europe.

For further information on OBN and its activities, please visit: http://www.obn.org.uk or to find out more about BioTrinity, please visit http://www.biotrinity.com

Contacts

OBN
David Boal, Director of Business Development
Tel: +44(0)845-5049-743
[email protected]


Citigate Dewe Rogerson
Janine Hagan
Tel: +44(0)20-7638-9571
[email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
Join us at Cloud Expo June 6-8 to find out how to securely connect your cloud app to any cloud or on-premises data source – without complex firewall changes. More users are demanding access to on-premises data from their cloud applications. It’s no longer a “nice-to-have” but an important differentiator that drives competitive advantages. It’s the new “must have” in the hybrid era. Users want capabilities that give them a unified view of the data to get closer to customers and grow business. The...
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, paneli...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
SYS-CON Events announced today that GrapeUp, the leading provider of rapid product development at the speed of business, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market acr...
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
SYS-CON Events announced today that Ayehu will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara California. Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infras...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...